Wyeth Pakistan & Pfizer Pakistan Limited have partnered with Shaukat Khanum Memorial Trust (SKMT) to provide free-of-cost diagnostic services to deserving patients
Wyeth Pakistan Limited, an affiliate of Pfizer Pakistan Limited, and SKMT have entered into a partnership on September 15, 2020 to enhance access of deserving patients to quality diagnostic services. This initiative is part of Wyeth and Pfizer’s programme “MASEEHA” and is in line with SKMT’s commitment to provide the highest quality laboratory diagnostic services to the people of Pakistan. The programme entails providing free-of-cost diagnostic services to a select group of patients including those suffering from Rheumatoid Arthritis (RA), AS, PsA, PsO, Juvenile Idiopathic Arthritis (JIA) and other inflammatory diseases, to start with.
Speaking at the signing ceremony of the contract, Dr.Asif Loya Medical Director of SKMCH&RC said that“We are pleased to join Wyeth Pakistan and Pfizer Pakistan in this campaign so as to extend the reach of our quality diagnostic services to deserving patients. For more than a quarter of a century, Shaukat Khanum has been at the forefront of providing world-class cancer care to people all across Pakistan. In addition, state-of-the-art diagnostic facilities have also become a hallmark of Shaukat Khanum’s brand name.
Syed Wajeeh, Country Manager of Wyeth Pakistan and Pfizer Pakistan, in his message said “Wyeth and Pfizer are committed to extending innovative solutions to patients who can benefit the most from them. Through Maseeha Diagnostics Campaign, we aim to unleash the true potential of innovative therapies and the breakthroughs it can bring about in patient’s lives through partnership with SKMCH&RC. The Agreement stands out as an excellent example of cooperation between these institutes in an area of public service and aims to relieve needy patients from the monetary burden of diagnostic tests.”
